A potential diagnostic marker for ovarian cancer: Involvement of the histone acetyltransferase, human males absent on the first

Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics

(2015) Paul C. McDonald et al.   Oncotarget

Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma

(2013) Yong Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Histone Acetyltransferase hMOF is Overexpressed in Non-small Cell Lung Carcinoma

(2011) Joon Seon Song et al.   Korean Journal of Pathology

Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer

(2011) Matthias Choschzick et al.   VIRCHOWS ARCHIV

The role of hypoxia inducible factor-1alpha in gynecological cancer

(2010) Laura M.S. Seeber et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Epigenetics of ovarian cancer: From the lab to the clinic

(2010) Reza Asadollahi et al.   GYNECOLOGIC ONCOLOGY

MOF and Histone H4 Acetylation at Lysine 16 Are Critical for DNA Damage Response and Double-Strand Break Repair

(2010) G. G. Sharma et al.   MOLECULAR AND CELLULAR BIOLOGY

Role of epigenomics in ovarian and endometrial cancers

(2010) Curtis Balch et al.   Epigenomics

Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome

(2009) S. E. Elsheikh et al.   CANCER RESEARCH

Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia

(2009) Alice Y.S. Law et al.   EXPERIMENTAL CELL RESEARCH

Subunit Composition and Substrate Specificity of a MOF-containing Histone Acetyltransferase Distinct from the Male-specific Lethal (MSL) Complex

(2009) Yong Cai et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Genetic alterations of HLA‐class II in ovarian cancer

(2008) Kirsten Kübler et al.   INTERNATIONAL JOURNAL OF CANCER